Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno
Stephan Windecker

Showing results (231-240 of 2,160) with videos related to

Pageof 216
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 20, 2026
Should clopidogrel replace aspirin for long-term therapy after percutaneous coronary intervention?Antonino Imbesi, Luigi Cutore, Davide Capodanno
European Heart Journal. Cardiovascular Imaging|September 16, 2016
Joint EACVI HIT/EAPCI young survey/ESC CoT survey: training and education for 'multimodality imaging in structural interventions': the rise of a new sub-specialty?Julia Grapsa, Vijay Kunadian, Davide Capodanno, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2022
Comment on Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularizationJuhani Knuuti, Antti Saraste, Davide Capodanno
Expert Review of Clinical Pharmacology|August 29, 2022
Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attackLorenzo Scalia, Dario Calderone, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2015
What about the risk of thrombosis with bioresorbable scaffolds?Davide Capodanno, Michael Joner, Marco Zimarino
The Canadian Journal of Cardiology|December 15, 2025
Contemporary Controversies Around Medical Ethics of Gene Therapy for Cardiovascular DiseaseAntonio Greco, Luigi Cutore, Davide Capodanno
International Journal of Cardiology|May 21, 2011
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in left main patients with intermediate Global RiskDavide Capodanno, Piera Capranzano, Corrado Tamburino
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 13, 2012
Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial: from statistics to clinical judgmentDavide Capodanno, Valeria Calvi, Corrado Tamburino
International Journal of Cardiology|September 16, 2011
A focused update on emerging prognostic determinants in distal left main percutaneous coronary interventionDavide Capodanno, Valeria Calvi, Corrado Tamburino
International Journal of Cardiology|November 10, 2009
Sirolimus- vs. paclitaxel-eluting stents in patients undergoing off-label percutaneous coronary interventionCettina Ruperto, Davide Capodanno, Corrado Tamburino
Pageof 216

Showing results (231-240 of 2,160) with videos related to

Sort By:
Pageof 216
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 20, 2026
Should clopidogrel replace aspirin for long-term therapy after percutaneous coronary intervention?Antonino Imbesi, Luigi Cutore, Davide Capodanno
European Heart Journal. Cardiovascular Imaging|September 16, 2016
Joint EACVI HIT/EAPCI young survey/ESC CoT survey: training and education for 'multimodality imaging in structural interventions': the rise of a new sub-specialty?Julia Grapsa, Vijay Kunadian, Davide Capodanno, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2022
Comment on Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularizationJuhani Knuuti, Antti Saraste, Davide Capodanno
Expert Review of Clinical Pharmacology|August 29, 2022
Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attackLorenzo Scalia, Dario Calderone, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2015
What about the risk of thrombosis with bioresorbable scaffolds?Davide Capodanno, Michael Joner, Marco Zimarino
The Canadian Journal of Cardiology|December 15, 2025
Contemporary Controversies Around Medical Ethics of Gene Therapy for Cardiovascular DiseaseAntonio Greco, Luigi Cutore, Davide Capodanno
International Journal of Cardiology|May 21, 2011
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in left main patients with intermediate Global RiskDavide Capodanno, Piera Capranzano, Corrado Tamburino
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 13, 2012
Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial: from statistics to clinical judgmentDavide Capodanno, Valeria Calvi, Corrado Tamburino
International Journal of Cardiology|September 16, 2011
A focused update on emerging prognostic determinants in distal left main percutaneous coronary interventionDavide Capodanno, Valeria Calvi, Corrado Tamburino
International Journal of Cardiology|November 10, 2009
Sirolimus- vs. paclitaxel-eluting stents in patients undergoing off-label percutaneous coronary interventionCettina Ruperto, Davide Capodanno, Corrado Tamburino
Pageof 216